[HTML][HTML] Differential roles for cortical versus sub-cortical noradrenaline and modulation of impulsivity in the rat
A Benn, ESJ Robinson - Psychopharmacology, 2017 - Springer
Rationale Atomoxetine is a noradrenaline re-uptake inhibitor licensed for the treatment of
adult and childhood attention deficit hyperactivity disorder. Although atomoxetine has …
adult and childhood attention deficit hyperactivity disorder. Although atomoxetine has …
Effects of atomoxetine on locomotor activity and impulsivity in the spontaneously hypertensive rat
M Turner, E Wilding, E Cassidy, EJ Dommett - Behavioural brain research, 2013 - Elsevier
Atomoxetine (ATX) is a commonly used non-stimulant treatment for Attention deficit
hyperactivity disorder (ADHD). It primarily acts to increase noradrenalin levels; however, at …
hyperactivity disorder (ADHD). It primarily acts to increase noradrenalin levels; however, at …
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit …
FP Bymaster, JS Katner, DL Nelson… - …, 2002 - Elsevier
The selective norepinephrine (NE) transporter inhibitor atomoxetine (formerly called
tomoxetine or LY139603) has been shown to alleviate symptoms in Attention …
tomoxetine or LY139603) has been shown to alleviate symptoms in Attention …
Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study
BACKGROUND: Atomoxetine, a selective noradrenaline reuptake inhibitor (SNRI) licensed
for the treatment of attention-deficit/hyperactivity disorder (ADHD), has been shown to …
for the treatment of attention-deficit/hyperactivity disorder (ADHD), has been shown to …
Altered gene expression in the prefrontal cortex of young rats induced by the ADHD drug atomoxetine
T Lempp, SW Toennes, C Wunder, OQ Russe… - Progress in Neuro …, 2013 - Elsevier
Atomoxetine (ATX), a selective norepinephrine reuptake inhibitor, is a non-stimulant
approved for the treatment of attention deficit/hyperactivity disorder (ADHD). Little is known …
approved for the treatment of attention deficit/hyperactivity disorder (ADHD). Little is known …
Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat
CJ Swanson, KW Perry, S Koch-Krueger, J Katner… - …, 2006 - Elsevier
Atomoxetine is a selective inhibitor of norepinephrine transporters and is currently being
used in the pharmacotherapy of attention deficit/hyperactivity disorder (ADHD). We have …
used in the pharmacotherapy of attention deficit/hyperactivity disorder (ADHD). We have …
Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine
S Wee, WL Woolverton - Drug and alcohol dependence, 2004 - Elsevier
Atomoxetine is a selective norepinephrine (NE) reuptake blocker that has recently been
marketed for the treatment of attention deficit hyperactivity disorder. The purpose of the …
marketed for the treatment of attention deficit hyperactivity disorder. The purpose of the …
Effects of atomoxetine on attention and impulsivity in the five-choice serial reaction time task in rats with lesions of dorsal noradrenergic ascending bundle
YP Liu, TS Huang, CS Tung, CC Lin - Progress in Neuro …, 2015 - Elsevier
Atomoxetine, a noradrenaline reuptake inhibitor (NRI), which is a non-stimulating medicine
that is used for the treatment of patients with attention deficit hyperactivity disorder (ADHD) …
that is used for the treatment of patients with attention deficit hyperactivity disorder (ADHD) …
Blockade of α2-adrenergic receptors in prelimbic cortex: impact on cocaine self-administration in adult spontaneously hypertensive rats following adolescent …
BM Baskin, BÁ Nic Dhonnchadha, LP Dwoskin… - …, 2017 - Springer
Rationale Research with the spontaneously hypertensive rat (SHR) model of attention
deficit/hyperactivity disorder demonstrated that chronic methylphenidate treatment during …
deficit/hyperactivity disorder demonstrated that chronic methylphenidate treatment during …
Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the …
Rationale Impulsivity is a key symptom of attention-deficit hyperactivity disorder (ADHD). The
use of the norepinephrine reuptake inhibitor, atomoxetine, to treat ADHD suggests that the …
use of the norepinephrine reuptake inhibitor, atomoxetine, to treat ADHD suggests that the …